Biointaxis is a biotechnology company that develops and offers advance technology products for neurodegenerative diseases.
Biointaxis has raised $2.3M in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Biointaxis's investors include European Commission, Ministry of Science and Innovation of Spain.
Biointaxis is headquartered in Barcelona, Spain.
Biointaxis is a biotechnology company that develops and offers advance technology products for neurodegenerative diseases.
Biointaxis is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biointaxis — Funding & Investors." VCBacked, October 23, 2024, https://www.vcbacked.co/company/biointaxis. Accessed August 14, 2026.
VCBacked. (2024). Biointaxis — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/biointaxis
{{cite web |title=Biointaxis — Funding & Investors |url=https://www.vcbacked.co/company/biointaxis |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated